1. National Research Council (U.S.). Subcommittee on the Tenth Edition of the RDAs. Recommended dietary allowances/Subcommittee on the Tenth Edition of the RDAs, Food and Nutrition Board, Commission on Life Sciences, National Research Council. Washington, D.C.: National Academy Press, 1989.
2. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, D.C.: National Academy Press, 2002; 770–3.
3. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832–5.
4. Wald N, Hack Shaw A. Folic acid and prevention of neural-tube defects. Lancet 1997; 350: 605.
5. Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet 2004; 125C: 12–21.
6. Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet C Semin Med Genet 2004; 125: 12–21.
7. Koren G, Piwko C, Ahn E., Boskovic R et al. Validation studies of the pregnancy unique quantification of emesis (PUQE) scores. J Obstet Gynecol (In Press).
8. Bendich A. Calcium supplementation and iron status of females. Nutr 2001; 17: 46–51.
9. Cook JD, Dassenko SA, Whittaker P. Calcium supplementation: effect on iron absorption. Am J Clin Nutr 1991; 53: 106–11.
10. Zijp IM, Korver O, Tijburg LB. Effect of tea and other dietary factors on iron absorption. Crit Rev Food Sci Nutr 2000; 40: 371–98.
11. Bothwell T.H. Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr 2000; 72: 257S–64S.
12. Ahn E, Kapur B, Koren G. Iron bioavailability in prenatal multivitamin supplements with separated and combined iron and calcium. J Soc Obst Gynecol Can 2004; 26: 809–15.
13. Koren G, Boscovic R, Hard M, Maltepe C, Navioz Y, Einarson A. Motherisk – PUQE scoring system for nausea and vomiting of pregnancy. Am J Obstetr Gynecol 2002; 186 (55 Suppl.): S228–31.
14. Leopold NA, Plansky M, Hurka MR. Drug adherence in Parkinson's disease. Mar Disord 2004; 19: 513–7.
15. Yavuz A, Tuncer M, Erdogran O et al. Is there any effect of compliance on clinical parameters of renal transplant recipients? Transplant Proc 2004; 36: 120–1.
16. Reimherr FW, Strong RE, Merchant BK et al.. Factors affecting return of symptoms 1 year after treatment in major depression. J Clin Psychiatry 2001; 6 (Suppl. 22): 16–23.
17. Smetana GW, Davis RB, Phillis RS. Factors that influence patient response to requests to change to a unified restrictive formulary. J Gen Intern Med 2004; 19: 1212–9.
18. Ekenved G, Halvorsen L, Solvell L. Influence of a liquid antacid on the absorption of different iron salts. Scand J Haematol Suppl 1976; 28: 65–77.
19. Crofton RW, Gvozdanovic D, Gvozdanovic S et al. Inorganic zinc and the intestinal absorption of ferrous iron. Am J Clin Nutr 1989; 50: 141–4.
20. Rossander-Hulten L, Brune M, Sandstrom B et al. Competitive inhibition of iron absorption by manganese and zinc in humans. Am J Clin Nutr 1991; 54: 152–6.
21. Thomsen JK, Prien-Larsen JC, Devantier A, Fogh-Andersen N. Low dose iron supplementation does not cover the need for iron during pregnancy. Acta Obstet Gynecol Scand 1993; 72: 93–8.

E.Ahn, N.Pairaudeau, N.Pairaudeau, Y.Cerat, B.Couturier, A.Fortier, E.Paradis and G.Koren.
 
A randomized cross over trial of tolerability and compliance of a micronutrient supplement with low iron separated 
from calcium vs high iron combined with calcium in pregnant women. BMC Pregnancy and Childbirth, 2006; 6: 10.